CGON — CG ONCOLOGY INC

Ownership history in NATIXIS  ·  1 quarter on record

This page tracks every 13F SEC filing in which NATIXIS reported a position in CG ONCOLOGY INC (CGON). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 12,437 — — 0.00% $501K $40.28
% of Fund (quarterly)    CGON price (monthly, adj. close)

Other funds also holding CGON

As of 2025 Q4 — sorted by position size

Seven Fleet Capital Management LP 47.85% Decheng Capital LLC 35.59% Foresite Capital Management V, LLC 3Y 25.36% Avidity Partners Management LP 3Y 17.64% ACORN CAPITAL ADVISORS, LLC 15.92% Elmind Capital, LP 6.03% TCG Crossover Management, LLC 3Y 5.04% Rosalind Advisors, Inc. 4.38% Octagon Capital Advisors LP 3Y 3.02% Kynam Capital Management, LP 3Y 2.51%
← Back to NATIXIS Holdings